Tobin Schilke - Chief Financial Officer at Crinetics Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
CRNX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Tobin Schilke since 10/9/2024

Holdings reported by Tobin Schilke for Crinetics Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 52K $2.03M $39.07 Mar 10, 2025 Direct
Stock Option (Right to Buy) 80K Mar 10, 2025 Direct Common Stock

Transactions reported by Tobin Schilke for Crinetics Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.